REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/20/2025
Back to search
Official data from USPTO
STARVANIP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/22/2025
Trademark type
Combined
Nice classes
5
Filing date
11/29/2019
Registration date
10/20/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
FAIRBANKS,RONALD L
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HAIM BIO CO., LTD.
Representatives
Jori R. Fuller McDonnell Boehnen Hulbert & Berghoff LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of deep vein thrombosis; drugs for medical purposesdrugs for the treatment of cerebral apoplexydrugs for affecting metabolismdrugs for affecting the peripheral nervous systemanti-inflammatory drugsimmunomodulatory drugscardiovascular drugsdrugs for treatment of deep vein thrombosisdrugs for treatment of systemic emboliformdrugs for treatment of venous thromboembolismdrugs affecting the central nervous systemdrugs for treatment of pulmonary embolismantibiotic drugsdrugs for the treatment of cancerdrugs effecting respiratory organs; medicines for human purposesmedicines for the treatment of cerebral apoplexymedicines for affecting metabolismmedicines for affecting the peripheral nervous systemanti-inflammatory medicinesimmunomodulatory medicinescardiovascular medicinesmedicines for treatment of deep vein thrombosismedicines for treatment of systemic emboliformmedicines for treatment of venous thromboembolismmedicines affecting the central nervous systemmedicines for treatment of pulmonary embolismantibiotic medicinesmedicines for the treatment of cancer or resistant cancermedicines effecting respiratory organs; pharmaceutical preparations for the treatment of systemic emboliform; pharmaceutical preparations for the treatment of venous thromboembolism; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of pulmonary emboliform; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2021
FIMP
FINAL DISPOSITION PROCESSED
02/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/20/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/31/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
ALIE
ASSIGNED TO LIE
07/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/24/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/24/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/24/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/24/2020
RFRR
REFUSAL PROCESSED BY MPU
03/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2020
CNRT
NON-FINAL ACTION WRITTEN
03/09/2020
DOCK
ASSIGNED TO EXAMINER
03/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/16/2020
Continuous trademark protection
Get notified about every new filing that threatens STARVANIP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.